448 Establishing the efficacy of naturally occurring endocannabinoid-like substance in an in vitro model of Fragile X Tremor/Ataxia Syndrome (FXT/AS)
OBJECTIVES/GOALS: FXT/AS is a devastating, rare neurological syndrome that negatively impacts movement and cognition and is suspected to induce mitochondria dysfunction. Currently, no effective pharmacological treatments for FXTAS exist. The goal is to restore mitochondrial viability using endocanna...
Main Authors: | Collis Brown, Sonya Sobrian, Tamaro Hudson |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2023-04-01
|
Series: | Journal of Clinical and Translational Science |
Online Access: | https://www.cambridge.org/core/product/identifier/S2059866123004752/type/journal_article |
Similar Items
-
400 Potential Drug Therapy for Fragile X Tremor/Ataxia Syndrome
by: Collis Brown, et al.
Published: (2022-04-01) -
95355 Potential Drug Therapy for Fragile X Tremor/Ataxia Syndrome
by: Collis Brown, et al.
Published: (2021-03-01) -
Late-onset Tremor and Ataxia Syndrome: Fragile X-Associated Tremor/Ataxia Syndrome and Neuroimaging Findings
by: Levent Öcek, et al.
Published: (2017-03-01) -
Fragile X-Associated Tremor/Ataxia Syndrome: An Illustrative Case
by: Chaewon Lee, et al.
Published: (2019-09-01) -
Ataxia as the Major Manifestation of Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Case Series
by: Maria Jimena Salcedo-Arellano, et al.
Published: (2020-05-01)